Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Fall Home Improvement
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about IONS
Recent news which mentions IONS
< Previous
1
2
3
4
5
Next >
Hereditary Angioedema Update Solidifies Intellia's Cell Therapy's Competitive Efficacy Profile: Analyst
June 12, 2023
Tickers
IONS
NTLA
Tags
Expert Ideas
Analyst Color
IONS
From
Benzinga
Analyst Creates Bullish Pitch On Ionis Pharmaceuticals Citing 'Strategic Pivot Underway'
June 07, 2023
Tickers
AZN
IONS
Tags
Expert Ideas
News
Briefs
From
Benzinga
Why Ionis Pharmaceutical Shares Are Trading Lower Wednesday
June 07, 2023
Tickers
IONS
Tags
Market News
Benzinga
Movers
From
Benzinga
Analyst Expectations for Ionis Pharmaceuticals's Future
June 07, 2023
Tickers
IONS
Tags
Analyst Ratings
Market News
Benzinga
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2023
May 04, 2023
Tickers
ABSI
BLDR
BLKB
CERE
Tags
INCY
NBIX
IONS
From
Benzinga
Recap: Ionis Pharmaceuticals Q1 Earnings
May 03, 2023
Tickers
IONS
Tags
BZI/Recaps
Earnings
Market News
From
Benzinga
Ionis Pharmaceuticals's Earnings Outlook
May 02, 2023
Tickers
IONS
Tags
Benzinga
IONS
BZI/EP
From
Benzinga
Biogen's Amyotrophic Lateral Sclerosis Drug Scores Conditional Approval From FDA
April 26, 2023
Tickers
BIIB
IONS
Tags
IONS
BIIB
Health Care
From
Benzinga
FDA grants accelerated approval to Biogen treatment for rare form of ALS
April 25, 2023
Tickers
BIIB
IONS
Tags
BIIB
IONS
From
MarketWatch
What's Going On With Biogen Stock Tuesday?
April 25, 2023
Tickers
BIIB
IONS
Tags
why it's moving
News
Movers
From
Benzinga
Biogen Announces Additional Cost Cutting Initiatives, Chops Certain Stroke, Gene Therapy Programs
April 25, 2023
Tickers
BIIB
IONS
Tags
Benzinga
Market News
BIIB
From
Benzinga
3 Biotech Stocks to Sell Before They’re 6 Feet Under
April 24, 2023
Tickers
ACRS
AMRS
IONS
Tags
ACRS
Market News
NASDAQ:AMRS,NASDAQ:ACRS,NASDAQ:IONS
From
InvestorPlace
AstraZeneca, Ionis Unveil Complete Phase 3 Data For ATTR Candidate, Says Drug Halts Disease Progression
April 24, 2023
Tickers
AZN
AZNCF
IONS
Tags
Biotech
Large Cap
AZN
From
Benzinga
Could This Rare-Disease Drug Candidate Become a Blockbuster?
April 19, 2023
Tickers
AZN
IONS
Tags
Recent Press Releases
IONS
AZN
From
Motley Fool
Analyst Upgrades Arrowhead Pharma Citing 'Attractive Risk/Reward'
April 12, 2023
Tickers
ALNY
ARWR
IONS
MRNA
Tags
NVO
Trading Ideas
Benzinga
From
Benzinga
Analyst Expectations for Ionis Pharmaceuticals's Future
April 11, 2023
Tickers
IONS
Tags
Market News
Analyst Ratings
Benzinga
From
Benzinga
AstraZeneca-Ionis Partnered Rare Disease Drug Data Shows Sustained Benefit; Drug Under FDA Review
March 27, 2023
Tickers
AZN
AZNCF
BXRX
IONS
Tags
AZN
Biotech
Health Care
From
Benzinga
FDA Adcomm Says Benefit-Risk Profile Favor Biogen's Tofersen For Inherited Neuro Disorder
March 23, 2023
Tickers
BIIB
IONS
Tags
News
Briefs
Biotech
From
Benzinga
Analyst Ratings for Ionis Pharmaceuticals
March 21, 2023
Tickers
IONS
Tags
Analyst Ratings
Market News
Benzinga
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 21, 2023
March 21, 2023
Tickers
ADC
AIZ
ALLO
ALNY
Tags
IONS
ATNX
Upgrades
From
Benzinga
Wall Street predicts approval for another ALS drug
March 21, 2023
Tickers
AMLX
BIIB
IONS
Tags
AMLX
BIIB
IONS
From
MarketWatch
Biogen Triumphs In Legal Battle Regarding Tecfidera, Delaying EU Generic Erosion For Another Year
March 16, 2023
Tickers
BIIB
IONS
Tags
Expert Ideas
Markets
News
From
Benzinga
Ionis Pharmaceuticals's Earnings Outlook
February 21, 2023
Tickers
IONS
Tags
Earnings
Market News
BZI/EP
From
Benzinga
Analyst Says Ionis' Additional Hereditary Angioedema Study Data Supports 'Highly Competitive Profile'
February 21, 2023
Tickers
IONS
Tags
News
Briefs
IONS
From
Benzinga
Analyst Expectations for Ionis Pharmaceuticals's Future
January 19, 2023
Tickers
IONS
Tags
BZI/AAR
IONS
Benzinga
From
Benzinga
EXAS Nears Key Buy Signal in Active Biotech ETF ARKG
January 11, 2023
Tickers
ARKG
EXAS
IONS
PACB
Tags
golden crossover
ARKG
PACB
From
ETF Trends
The Latest Analyst Ratings for Ionis Pharmaceuticals
December 21, 2022
Tickers
IONS
Tags
Analyst Ratings
Market News
BZI/AAR
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 21, 2022
December 21, 2022
Tickers
ADPT
AIMC
AMV
APPN
Tags
BLCO
DLO
ZIMV
From
Benzinga
Ionis Pharmaceuticals Earnings Perspective: Return On Capital Employed
December 13, 2022
Tickers
IONS
Tags
Benzinga
IONS
BZI/ROCE
From
Benzinga
Gene Deal Adds New Dimension to Biotech ETF SBIO
November 16, 2022
Tickers
ALPS
IONS
SBIO
Tags
ALPS
SBIO
IONS
From
ETF Trends
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.